Individualized approaches to determining likelihood of ASD caseness
Individualized approaches to determining likelihood of ASD caseness
批准号:
10522317
负责人:
Somer L. Bishop
金额:
$82.33万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2025-04-30
关键词:
AffectAgeAssessment toolAttention deficit hyperactivity disorderAutism DiagnosisAutism diagnosticBehavioralCase StudyCharacteristicsChildChild Behavior ChecklistClassificationClinicalClinical ResearchDataData AnalysesDecision MakingDecision TreesDevelopmentDevelopmental Delay DisordersDiagnosisDiagnosticEvaluationExplosionFemaleGoalsGuidelinesHealthHeterogeneityIndividualInfantIntellectual functioning disabilityInterviewKnowledgeLanguageLanguage DisordersLightLiteratureMachine LearningMale AdolescentsMeasuresMethodsPaperParentsParticipantPerformancePersonsPhenotypePopulationPopulation CharacteristicsPredictive ValueProblem behaviorProceduresProcessPropertyPsychometricsQuestionnairesRecommendationReportingResearchResearch PersonnelResearch Project GrantsResourcesRiskSamplingScreening procedureSensitivity and SpecificityServicesSpecific qualifier valueSpeechStandardizationStretchingSubgroupSymptomsSystemTechniquesTestingTimeToddlerTriageUpdateValidationWeightWorkYouthartificial neural networkautism diagnostic observation scheduleautism spectrum disorderautistic childrenbasebehavioral phenotypingbiological sexclinical diagnosisclinically significantcognitive abilitycomorbiditydiagnostic accuracydiagnostic platformdiagnostic toolethnic minoritygirlsimprovedindividual variationinstrumentnext generationpersonalized approachphrasespreventracial and ethnicrecruitscreeningskillssocialsocial communicationstudy characteristicstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Ongoing development and validation of screening and diagnostic tools has been a major focus of research in
autism spectrum disorders (ASD) during the past 30 years. Diagnostic validity of several widely used tools has
been established by showing that, in most cases, children with ASD score above established cut-offs, whereas
children with non-ASD score below cut-offs. However, a growing body of literature indicates that sensitivity and
specificity of ASD symptom measures varies significantly based on the characteristics of the study population.
This means that the ability of a given tool to differentiate children with and without ASD is variable, and is affected
by an individual's demographic (age, sex), developmental (cognitive ability, language level), and/or behavioral
(clinically significant behavior problems) profile.
The long-term goal of the proposed research is to transform screening and diagnostic practices through
increased individualization of measure selection and interpretation. Phenotypic heterogeneity of youth referred
for possible ASD is a well-recognized challenge that prevents one-size-fits-all assessment approaches from
being validly employed. Yet, with ever-growing demands for such services, clinical and research entities
increasingly rely on specified batteries to make decisions about triage and diagnosis. While use of standardized
tools offers many advantages, uniform application or interpretation of specific instruments disregards the vast
individual heterogeneity that is a hallmark of ASD. Thus, the field is in need of updated practices, wherein tools
are selected, combined, and interpreted in the context of an individual child's presentation, with specific reference
to how likely it is that scores on a given test or combination of tests will indicate ASD caseness for that child.
Toward this end, the proposed secondary data analysis will identify which tools, and combinations of tools, work
best for identifying ASD in sub-groups of youth with shared demographic, developmental, and/or behavioral
phenotypes (e.g., in toddler girls with phrase speech vs. verbally fluent adolescent boys with clinically elevated
behavior problems). We will analyze data from several widely-used ASD measures, aggregated from more than
17,500 children between the ages of 18 months and 17 years, 11 months. These youth were either clinically
referred for ASD diagnostic assessment, assessed due to heightened risk for ASD or other developmental
delays, or recruited for ASD-focused research projects. They were assigned a best-estimate diagnosis of ASD
or non-ASD (e.g., intellectual disability, ADHD, language disorder) by expert clinicians or clinical-researchers
following a comprehensive assessment. By considering the interplay between individual characteristics and
instrument scores in the largest sample to date, the proposed study will move the field toward more individualized
approaches for establishing ASD caseness. Findings from this study will also directly inform the development of
the next generation of tools, procedures, and electronic platforms for diagnostic assessment of ASD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Individualized approaches to determining likelihood of ASD caseness
-
批准号:10656512
-
项目类别:
-
资助金额:$79.03万
-
财政年份:2022
-
负责人:Somer L. Bishop
-
依托单位:
Development of a standardized measure of social-communication abilities for children with neurodevelopmental disorders
-
批准号:10618757
-
项目类别:
-
资助金额:$12.02万
-
财政年份:2022
-
负责人:Somer L. Bishop
-
依托单位:
Development of a standardized measure of social-communication abilities for children with neurodevelopmental disorders
-
批准号:10198960
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2017
-
负责人:Somer L. Bishop
-
依托单位:
2/2 Development of a Screening Interview for Research Studies of ASD
-
批准号:7844613
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2009
-
负责人:Somer L. Bishop
-
依托单位:
2/2 Development of a Screening Interview for Research Studies of ASD
-
批准号:7945340
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:Somer L. Bishop
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: